the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
Last Updated on October 28, 2017 by Joseph Gut – thasso October 28, 2017 – How Precise is Precision Medicine When Applied to Diverse Populations? This was the question raised in a very recent article published in Front Line Genomics …
Is precision medicine un-precise when applied to diverse world populations? Read more »
Last Updated on October 22, 2017 by Joseph Gut – thasso October 21, 2017 – Just seen on PubMed: Ziegelstein RC J Pers Med 2017 Oct;7(4) PMID: 29035320 Abstract Clinical practice guidelines have been developed for many common conditions …
Personomics: The Missing Link from Precision Medicine to Personalized Medicine Read more »
Last Updated on October 19, 2017 by Joseph Gut – thasso October 19, 2017 – The American Food & Drug Administration (FDA) just approved Axicabtagene Ciloleucel (Yescarta), a cell-based gene therapy, to treat adult patients with certain types of large …
Axicabtagene Ciloleucel (Yescarta) gene therapy for diffuse large B-cell lymphoma Read more »
Last Updated on October 15, 2017 by Joseph Gut – thasso October 15, 2017 – According to the quarterly safety report April – June 2017 by the American Food & Drug Administration (FDA), originating from the FDA Adverse Event Reporting System …
Diabetes: Is rhabdomyolysis associated with DPP-IV inhibitors? Read more »
Last Updated on October 1, 2017 by Joseph Gut – thasso October 02, 2017 – Seemingly incurable childhood brain tumor is one of the most devastating clinical diagnosis a young patient and her/his family can get. For many, the associated sufferance …